Cabozantinib

Results: 13



#Item
1COMETRIQ, INN-Cabozantinib

COMETRIQ, INN-Cabozantinib

Add to Reading List

Source URL: www.ipsen.cz

Language: Czech - Date: 2016-11-25 11:43:12
    2 What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral

    What is the Hottest New Molecule in RCC? (excluding targeted immunotherapeutics) Emiliano Calvo, MD PhD START Madrid, Centro Integral

    Add to Reading List

    Source URL: www.euikcs.com

    Language: English - Date: 2014-05-13 15:09:11
    3Legend Open to Accrual Pending Hepatocellular Carcinoma

    Legend Open to Accrual Pending Hepatocellular Carcinoma

    Add to Reading List

    Source URL: cancer.ucsf.edu

    Language: English - Date: 2014-10-06 14:59:53
    4

    PDF Document

    Add to Reading List

    Source URL: www.mirg.org

    Language: English - Date: 2010-10-19 13:01:07
    5cabozantinib 20mg and 80mg hard capsules (Cometriq®) Swedish Orphan Biovitrum Ltd. SMC No[removed]February 2015

    cabozantinib 20mg and 80mg hard capsules (Cometriq®) Swedish Orphan Biovitrum Ltd. SMC No[removed]February 2015

    Add to Reading List

    Source URL: www.scottishmedicines.org.uk

    Language: English
    6COMETRIQ™ (cabozantinib) Label

    COMETRIQ™ (cabozantinib) Label

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2012-11-29 16:46:05
    73rd-Line Trials A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma (METEOR) NCT01865747 Tom Baker Cancer Centre Cross Cancer Institute

    3rd-Line Trials A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma (METEOR) NCT01865747 Tom Baker Cancer Centre Cross Cancer Institute

    Add to Reading List

    Source URL: www.kidneycancercanada.ca

    - Date: 2014-08-01 14:57:41
      8An Update on Novel Therapies for Advanced Thyroid Cancer: When to Start and What to Use Case Discussions - Presenter: Mimi I. Hu, MD Learning Objectives: - Understand when to consider novel therapies for advanced thyroid

      An Update on Novel Therapies for Advanced Thyroid Cancer: When to Start and What to Use Case Discussions - Presenter: Mimi I. Hu, MD Learning Objectives: - Understand when to consider novel therapies for advanced thyroid

      Add to Reading List

      Source URL: www.thyroid.org

      Language: English - Date: 2014-04-02 19:28:42
      9Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute 6130 Executive Blvd, *Suite 7149 Rockville, Maryland[removed]Phone (301): [removed]

      Cancer Therapy Evaluation Program Division of Cancer Treatment and Diagnosis National Cancer Institute 6130 Executive Blvd, *Suite 7149 Rockville, Maryland[removed]Phone (301): [removed]

      Add to Reading List

      Source URL: ctep.cancer.gov

      Language: English - Date: 2013-01-26 11:20:23
      10LB-353: Pediatric Preclinical Testing Program (PPTP) Stage 1 Evaluation of Cabozantinib Malcolm A. Smith1, Min Kang2, C. Patrick Reynolds2, Richard Gorlick3, E. Anders Kolb4, John M. Maris5, Stephen T. Keir6, Catherine A

      LB-353: Pediatric Preclinical Testing Program (PPTP) Stage 1 Evaluation of Cabozantinib Malcolm A. Smith1, Min Kang2, C. Patrick Reynolds2, Richard Gorlick3, E. Anders Kolb4, John M. Maris5, Stephen T. Keir6, Catherine A

      Add to Reading List

      Source URL: pptp.nchresearch.org

      Language: English - Date: 2013-04-12 08:49:41